Weiwei Fu
Qingdao, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 29 publications
Correction to: Prediction of double expression status of primary CNS lymphoma using multiparametric MRI radiomics combined with habitat radiomics: a double-center study.
Journal: Journal of neuro-oncology
Published: September 19, 2025
Brain invasion as a diagnostic histological feature of atypical meningiomas: Not a standalone diagnostic criterion.
Journal: Neuro-oncology advances
Published: September 09, 2025
Prediction of double expression status of primary CNS lymphoma using multiparametric MRI radiomics combined with habitat radiomics: a double-center study.
Journal: Journal of neuro-oncology
Published: July 09, 2025
High-grade B-cell lymphoma with 11q aberrations originating from bilateral ovaries: report of a case
High-grade B-cell lymphoma with 11q aberrations originating from bilateral ovaries: report of a case
Journal: Zhonghua bing li xue za zhi = Chinese journal of pathology
Published: March 03, 2025
Light chain amyloidosis with cuticular cysts as the initial symptom complicated with multiple myeloma: report of a case
Journal: Zhonghua bing li xue za zhi = Chinese journal of pathology
Published: October 31, 2024
The "purfling sign": a new imaging marker for the diagnosis of primary CNS lymphoma.
Journal: La Radiologia medica
Published: July 30, 2024
Weakly supervised pathological differentiation of primary central nervous system lymphoma and glioblastoma on multi-site whole slide images.
Journal: Journal of medical imaging (Bellingham, Wash.)
Published: June 10, 2024
Primary Systemic Amyloidosis Characterized by Multiple Keratinous Cysts: A Case Report.
Journal: Journal of cutaneous pathology
Published: February 27, 2024
Oligosarcoma: report of a case
Journal: Zhonghua bing li xue za zhi = Chinese journal of pathology
Published: August 01, 2023
A Clinicopathological and Molecular Analysis of Sellar/Suprasellar Neurocytoma Mimicking Pituitary Adenoma.
Journal: Frontiers in endocrinology
Published: January 24, 2022
NUAK family kinase 2 is a novel therapeutic target for prostate cancer.
Journal: Molecular carcinogenesis
Published: October 06, 2021
Last Updated: 09/26/2026